News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Anderson Kenneth Carl
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Anderson Kenneth Carl (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 6,617 shares
@ $1.7, valued at
$11.2k
|
|
| 07/05/2023 |
4
| Anderson Kenneth Carl (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 3,976 shares
@ $2.83, valued at
$11.3k
|
|
| 06/16/2023 |
4
| Anderson Kenneth Carl (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 26,000 options to buy
@ $3.61, valued at
$93.9k
|
|
| 04/04/2023 |
4
| Anderson Kenneth Carl (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 3,516 shares
@ $3.2, valued at
$11.3k
|
|
| 01/06/2023 |
4
| Anderson Kenneth Carl (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Exercised 268 options to buy
@ $2.11, valued at
$565.5
Exercised 444 options to buy
@ $4.98, valued at
$2.2k
|
|
| 01/04/2023 |
4
| Anderson Kenneth Carl (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 1,568 shares
@ $6.38, valued at
$10k
|
|
| 10/04/2022 |
4
| Anderson Kenneth Carl (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 1,150 shares
@ $8.69, valued at
$10k
Exercised 267 options to buy
@ $2.11, valued at
$563.4
Exercised 445 options to buy
@ $4.98, valued at
$2.2k
|
|
| 07/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2022 |
4
| Anderson Kenneth Carl (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 341 shares
@ $26.46, valued at
$9k
|
|
| 01/26/2022 |
4
| Anderson Kenneth Carl (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Exercised 803 options to buy
@ $2.11, valued at
$1.7k
Exercised 1,334 options to buy
@ $4.98, valued at
$6.6k
|
|
| 01/18/2022 |
4
| Anderson Kenneth Carl (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 278 shares
@ $31.58, valued at
$8.8k
|
|
| 10/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2020 |
4
| Anderson Kenneth Carl (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Converted 18,040 shares
@ $0
Converted 18,040 shares
@ $0
Converted 41,244 shares
@ $0
Converted 41,244 shares
@ $0
Converted 16,939 shares
@ $0
Converted 16,939 shares
@ $0
Converted 152,160 preferred shares
@ $0
Converted 152,160 preferred shares
@ $0
Converted 347,840 preferred shares
@ $0
Converted 347,840 preferred shares
@ $0
Converted 142,857 preferred shares
@ $0 |
|
| 10/05/2020 |
4
| Anderson Kenneth Carl (Director) has filed a Form 4 on C4 Therapeutics, Inc.|
Txns:
| Granted 17,786 options to buy
@ $19, valued at
$337.9k
|
|
|
|